Biomerica, Inc. (BMRA)
NASDAQ: BMRA · IEX Real-Time Price · USD
0.445
-0.003 (-0.56%)
At close: Jul 2, 2024, 4:00 PM
0.444
-0.001 (-0.27%)
After-hours: Jul 2, 2024, 7:53 PM EDT

Biomerica Revenue

Biomerica had revenue of $5.41M in the twelve months ending February 29, 2024, down -43.29% year-over-year. Revenue in the quarter ending February 29, 2024 was $1.02M, a -8.46% decrease year-over-year. In the fiscal year ending May 31, 2023, Biomerica had annual revenue of $5.34M, a decrease of -71.71%.

Revenue (ttm)
$5.41M
Revenue Growth
-43.29%
P/S Ratio
1.38
Revenue / Employee
$87,181
Employees
62
Market Cap
7.49M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
May 31, 20235.34M-13.53M-71.71%
May 31, 202218.87M11.67M162.13%
May 31, 20217.20M506.32K7.57%
May 31, 20206.69M1.49M28.69%
May 31, 20195.20M-363.50K-6.53%
May 31, 20185.56M-227.49K-3.93%
May 31, 20175.79M651.85K12.68%
May 31, 20165.14M177.44K3.58%
May 31, 20154.96M-158.08K-3.09%
May 31, 20145.12M-1.35M-20.89%
May 31, 20136.47M391.83K6.44%
May 31, 20126.08M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CareMax 810.36M
XWELL 31.77M
Precipio 15.81M
Pulmatrix 11.68M
NeuroMetrix 5.27M
PAVmed 3.02M
Mainz Biomed B.V. 895.48K
Mangoceuticals 844.87K
Revenue Rankings